|
|
| |
| |
Past CCT Seminars
|
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006 2007 |
2007
| Date |
Topic |
Speaker/Discussant |
04 Oct |
Uveitis and the Tower
of Babel: Standardizing clinical research |
Douglas A. Jabs, MD,
MBA |
01 Nov |
A Pure Likelihood
Approach for Adaptive Clinical Trials |
Jeffrey D. Blume,
PhD |
06 Dec |
Results of the TAPE
trial -- The placebo effect in asthma |
Robert Wise, MD |
03 Jan |
Getting the Most
From Clinical Trials: The Submacular Surgery Trials |
Barbara S. Hawkins,
PhD |
07 Feb |
Government and Industry
Collaborations for Treatment of Age-Related Macular
Degeneration and Other Retinal Diseases
|
Emily Chew, MD |
07 Mar |
Effect of Mindfulness-Based
Stress Reduction with Rheumatoid Arthritis Patients
|
Elizabeth Kimbrough Pradhan,
PhD |
04 Apr |
The STAR Breast Cancer
Prevention Trial - CANCELLED
|
Kala Visvanathan, MBBS,
FRACP, MHS |
02 May |
The Precursors Study:
50 years of follow-up |
Michael J. Klag, MD,
MPH |
|
2006
| Date |
Topic |
Speaker/Discussant |
03 May |
The Intersection of Clinical Trials and
Meta-Analysis |
Kay Dickersin, PhD |
05 Apr |
Cardiovascular and Cerebrovascular Risks
in ADAPT |
Barbara Martin, PhD |
01 Mar |
TBA |
Linda P. Fried, MD, MPH |
01 Feb |
Clinical Trial of Azithromycin for Trichiasis
in Ethiopia: Special Issues in Developing Counties |
Sheila West, PhD |
04 Jan |
A Cluster Randomized Trial of Guided
Care for Frail Elderly People |
Charles Boult, MD, MPH, MBA |
|
| |
 |
| |
2005
Date |
Topic |
Speaker/Discussant |
07 Dec |
Publication Policies and Procedures in
Multicenter Trials |
Neil M. Bressler, MD |
02 Nov |
The Effectiveness of t-PA in Treating
Acute Ischemic Stroke: Clinical, Statistical and Policy
Issues |
Thomas Louis, PhD |
05 Oct |
Clinical Trials and Public Health |
Alfred Sommer, MD, MHS |
04 May |
The Dying Child: Terrible Questions,
Few Answers. A Reporter's Perspective on the Hardest
Story |
Diana Sugg |
06 Apr |
Confessions of a Recovering Trialist |
Charles Flexner, MD |
02 Mar |
Clinical Trials and IRBs |
Mark Steinhoff, MD |
16 Mar |
The NIH Roadmap and its Impact on Clinical
Trials |
Robert Nussenblatt, MD |
02 Feb |
Lessons from Landmark Clinical Trials:
Tales from Project ImpACT |
Steven Goodman, MD, PhD |
05 Jan |
Protection of Human Subjects
of Research: Where are We? Where are We Going? |
Bernard A. Schwetz, DVM,
PhD |
|
| |
|
| |
2004
Date |
Topic |
Speaker/Discussant |
01 Dec |
Treatment vs Prevention Trials |
Steven Piantadosi, MD, PhD |
03 Nov |
The Hijacking of Clinical Trials |
Curtis L. Meinert, PhD |
05 May |
The Impact of Scientific Uncertainty
on the Development of Health Policy |
Leon Gordis, MD, MPH, DrPH |
07 Apr |
The Evolution of the AIDS Activist Movement |
Kevin Robert Frost |
03 Mar |
Conduct of Large Randomized Clinical
Trials |
Keith West, MPH, DrPH |
04 Feb |
The Cochrane Eyes and Vision Group-US
Project |
Kay Dickersin, PhD |
07 Jan |
Contributions of American
Indians in the Global Control of Infectious Diseases |
Mathuram Santosham, MD, MPH |
|
| |
|
| |
2003
Date |
Topic |
Speaker/Discussant |
03 Dec |
Treatment Effects Monitoring Committee
(TEMC) |
Barbara Martin, PhD |
05 Nov |
Lessons from Two Decades of Diet-Blood
Pressure Trials |
Lawrence S. Appel, MD, MPH |
01 Oct |
Trials & Tribulations of a Clinician
Trialist |
Douglas A. Jabs, MD, MBA |
07 May |
Logistics and Challenges Associated with
Coordinating Center Activities in the Women’s Health
Initiative |
Garnet L. Anderson, PhD |
02 Apr |
Randomized Evaluation of Mechanical Assistance
for the Treatment of Congestive Heart Failure (REMATCH) |
Annetine Gelijns, PhD |
05 Mar |
Recent problems in conducting vaccine
trials
in children |
Neal A. Halsey, MD |
05 Feb |
The Impact of Scientific Uncertainty
on the Development of Health Policy |
Leon Gordis, MD, DrPH |
08 Jan |
Privacy Protection Legislation
and Impact on Clinical Trials |
Joanne Pollak, JD |
|
| |
|
| |
2002
Date |
Topic |
Speaker/Discussant |
04 Dec |
The Placebo Effect |
Robert Wise, MD |
06 Nov |
"Why R.A. Fisher is Important (Even
if He Wasn’t Influential):
Randomization, Statistical Inference and Uncertainty" |
Harry Marks, PhD |
02 Oct |
Unresolved Issues in IRBs and Clinical
Trials |
Paul S. Lietman, MD
Curtis L. Meinert, PhD |
01 May |
Collaborative Ocular Melanoma Study:
Results of a Randomized Trial |
Barbara S. Hawkins, PhD |
03 Apr |
Clinical Trials and Conflicts of Interest |
Frank Davidoff, MD, FACP |
06 Mar |
Placebo Controls |
Robert Temple, MD |
06 Feb |
National Emphysema Treatment Trial -
Subgroup Results |
Steven Piantadosi, MD, PhD |
09 Jan |
The Conflict Between Observation
and Experiment |
Jonathan Samet, MD, MS |
|
| |
|
| |
2001
Date |
Topic |
Speaker/Discussant |
05 Dec |
The Languages of Epidemiology |
John M. Last, MD, FRACP, FRCPC, FFCM |
07 Nov |
Community Intervention Trials for Obesity |
Robert Jeffery, PhD |
03 Oct |
Vitamin A and Human Disease: Who Needs
Trials |
Alfred Sommer, MD, MHS |
02 May |
Clinical Trials and IRBs |
Donald S. Burke, MD |
04 Apr |
Risks and Benefits Applying Prevention
Trials Results and Recruitment for the Next Generation
of Trials |
Kathy J. Helzlsouer, MD |
07 Mar |
Challenges of a Flu Trial |
Robert Wise, MD |
07 Feb |
Issues in Compliance and Credibility
in Clinical Trials |
Eliot Lee Marshall, AB |
03 Jan |
Ethical and Practical Issues
in Trials in Developing Countries |
Joanne Katz, ScD |
|
| |
|
| |
2000
Date |
Topic |
Speaker/Discussant |
06 Dec |
Childhood Asthma Management Program (CAMP)
Results |
James Tonascia, PhD |
01 Nov |
Vaccination Trials Against TB: Lessons
Learned |
George W. Comstock, MD, DrPH |
04 Oct |
The State and Nature of Clinical Trials |
Curtis L. Meinert, PhD |
03 May |
Heart and Estrogen/Progestin Replacement
Study (HERS) |
Trudy Bush, PhD |
05 Apr |
Issues in Pediatric Trials |
Andrea Ruff, MD |
01 Mar |
Alzheimer Disease Prevention Trials |
John Breitner, MD |
02 Feb |
Issues in Vaccine Trials |
Mark Steinhoff, MD |
05 Jan |
Political Issues in the National
Emphysema Treatment Trial (NETT) |
Steven Piantadosi, MD, PhD |
|
| |
|
| |
1999
Date |
Topic |
Speaker/Discussant |
01 Dec |
Ethical Challenges in the Prevention
of Retrolental Fibroplasia: The “RLF Trial” Revisited |
Arnall Patz, MD |
03 Nov |
What Medical Students Should Know About
Clinical Trials |
Leon Gordis, MD, DrPH |
06 Oct |
Clinical Trials, Past, Present and Future |
Curtis L. Meinert, PhD |
12 May |
Clinical Trials in Complementary Medicine:
Trials and Tribulations |
Brian Berman, MD |
07 Apr |
A Web-Based Clinical Trials Support Tool
Medical Director |
Daniel S. Reshef, MD, MPH |
03 Mar |
Exciting Challenges in Medical Device
Clinical Trials |
Gregory Campbell, PhD |
03 Feb |
Controlled Trials in Developing Countries |
Neal A. Halsey, MD |
06 Jan |
Early Developmental Trial
Designs in Oncology |
Steven Piantadosi, MD, PhD |
|
| |
|
| |
1998
Date |
Topic |
Speaker/Discussant |
02 Dec |
Issues Arising from Randomized Trials
of Home Treatment of Severe Malaria
|
Richard H. Morrow, Jr, MD |
04 Nov |
Lorenzo’s Oil Trial In Retrospect |
Hugo W. Moser, MD |
07 Oct |
Policy vs Reality in Clinical Trials |
Curtis L. Meinert, PhD |
06 May |
Ethics of Placebos |
Nancy Min, PhD |
01 Apr |
Outcomes Research and Clinical Trials |
Mark Danese
PhD student |
04 Mar |
Impact of Population Heterogeneity on
the Design of Developmental Trials |
Steven Piantadosi, MD, PhD |
04 Feb |
Statistical Methods for Clinical Trials
of Vaccines |
Janet Wittes, PhD |
07 Jan |
Planning Cost-Effectiveness
Analyses in Clinical Trials: Dysfunctional Uterine Bleeding |
Kevin Frick, PhD |
|
| |
|
| |
1997
Date |
Topic |
Speaker/Discussant |
03 Dec |
Information-Based Design and Monitoring
of Group Sequential Studies |
Daniel Scharfstein, PhD |
05 Nov |
Design Strategies in Dementia Prevention
Trials with New or Old NSAID Therapies |
Walter Stewart, PhD |
01 Oct |
Competency vs Objectivity in Clinical
Trials |
Curtis L. Meinert, PhD |
12 Mar |
Assessing the Effect of HIV
Vaccination on Infectiousness |
Wasima Rida, PhD |
|
| |
|
| |
1996
Date |
Topic |
Speaker/Discussant |
13 Nov |
Analyzing Clinical Trials with Patient
Crossover and Dropout |
Daniel F. Heitjan, PhD |
04 Oct |
Conceptual Errors in the Use of Statistics
in Published Medical Research |
Douglas G. Altman, DSc |
11 Sep |
Apples and Oranges?: Modeling Heterogeneity
in Meta-Analysis |
John P.A. Ioannidis, PhD |
12 Jun |
General Faculty Meeting |
All Center Faculty |
17 Apr |
Current FDA Reform (Deform?) Legislation |
Sidney Wolfe, MD |
13 Mar |
Quantitative Compliance Monitoring |
Charles Flexner, MD |
14 Feb |
Figures Don’t Lie,
But Liars Figure: A Case Study of Fraud in Clinical Trials |
Craig Hendrix, MD |
|
| |
|
| |
1995
Date |
Topic |
Speaker/Discussant |
13 Dec |
Adjusting Survival Curves for Confounders:
A Review and A New Method |
Javier Nieto, MD, PhD
Josef Coresh, MD, PhD |
11 Oct |
“Picturing” Clinical Trials:
The Art in Medicine |
Steven Piantadosi, MD, PhD |
13 Sep |
The Adequacy of the Consent Process and
Patients’ Understanding of Clinical Research: Results
of Two Studies Conducted for the President’s Advisory
Committee on Human Radiation Experimentation |
Gail Geller, ScD
Steven Goodman, MD, PhD
Nancy Kass, ScD |
14 Jun |
The Cochrane Collaboration: A Progress
Report |
Kay Dickersin, PhD
Steven Goodman, MD, PhD |
17 May |
General Faculty Meeting |
All Faculty, CCT |
12 Apr |
When Bad Things Happen: A Case Study
of the FIAU Trials |
Curtis L. Meinert, PhD |
08 Mar |
Measuring Outcomes: The 18th Century
Inoculation Debates |
Harry M. Marks, PhD |
08 Feb |
Publication and Reporting of Phase I
Clinical Trials |
Marcy Winget
PhD student |
01 Jan |
Misconduct in Clinical Trials |
Marie Diener-West
Barbara S. Hawkins
Claudia S. Moy |
|
| |
|
| |
1994
Date |
Topic |
Speaker/Discussant |
14 Dec |
Perioperative Transfusion & Cardiac
Morbidity A Clinical Trial |
Rose Christopherson, MD, PhD |
08 Nov |
Society for Clinical Trials Program Talks |
CCT Staff and Faculty |
12 Oct |
Making the Data Fit the Analysis: A Case-Cohort
Analysis of a Case-Coverage Vaccine Study |
Lawrence H. Moulton, PhD |
14 Sep |
Dementia After Death? A Method for Survival
Analysis when Survival is Not the Outcome |
Leonardo D. Epstein, PhD |
08 Jun |
Faculty Meeting |
CCT Faculty |
13 Apr |
Intention to Treat vs Treatment-Received
Analysis in Clinical Trials |
Cynthia B. Saiontz
ScM student |
12 Jan |
Reader Based Analysis of
Clinical Trials Bayesian Statistics and Expert Systems |
Harold Lehmann, MD, PhD |
|
| |
|
| |
1993
Date |
Topic |
Speaker/Discussant |
08 Dec |
Putting Clinical Trials Into Practice
at the National Health Service |
Muir Gray, CBE, MD, FRCP |
13 Oct |
Society for Clinical Trials Program Talks |
CCT Staff and Faculty |
08 Sep |
Does Peer Review Make a Difference? The
Results of a study |
Steven N. Goodman, MD, PhD |
09 Jun |
General Faculty Meeting |
Open Discussion |
12 May |
Meinert on Clinical Trials |
Curtis L. Meinert, PhD |
14 Apr |
Treatment Trials and Drug Company Agreements |
Curtis L. Meinert, PhD |
10 Mar |
Ethical Dilemmas in Continuing a Zidovudine
Trial After Early
Termination of Similar Trials |
Open Discussion |
10 Feb |
Two Ethical Problems in Clinical Trials |
Ruth Faden, PhD |
13 Jan |
Identical Survival Models
from Contracting Assumptions: Example and Discussion |
Steven Piantadosi, MD, PhD |
|
| |
|
| |
1992
Date |
Topic |
Speaker/Discussant |
09 Dec |
Threats to Clinical Trials and What We
Can Do About Them |
Open discussion |
11 Nov |
Inclusion of Women and Minorities in
Clinical Trials: The Current Debate |
Janet Wittes, PhD |
14 Oct |
Recent Developments in the Design of
Phase I and II Clinical Trials |
Richard Simon, PhD |
16 Sep |
Directions for Clinical Trials Research
in the 90s |
Faculty presentations |
20 May |
Plans for 1992-93 |
CTTP Faculty |
|
| |
|
| |
1991
Date |
Topic |
Speaker/Discussant |
11 Dec |
SOCA: Lessons in Strategy and Tactics |
Curtis L. Meinert, PhD |
09 Oct |
Randomization From the First Patient |
Barbara S. Hawkins, PhD |
11 Sep |
Clinical Trials After Efficacy is Established:
Cost and Cost Effectiveness as Endpoints |
Neil Powe, MD |
05 Jun |
The VA Cooperative Studies Program: A
Model for Multicenter Clinical Trials? |
Joseph F. Collins, ScD |
01 May |
General Faculty Meeting |
CCT Faculty |
03 Apr |
Analysis of Pre-Post Data in Non- Randomized
Trials |
Kenrad Nelson, MD
Alvaro Muñoz, PhD |
06 Mar |
Are Randomized Clinical Trials Ethical?
A Review of the Debate |
Steve N. Goodman, MD, PhD |
06 Feb |
Estimating A Drug Effect
When All Patients At Risk Are Treated; is Herb Robbins
Crazy? |
Scott L. Zeger, PhD |
|
| |
|
| |
1990
Date |
Topic |
Speaker/Discussant |
05 Dec |
Underrepresented Groups in Clinical Trials |
Kay Dickersin, PhD |
07 Nov |
Enthusiasm for Cancer Therapies at Different
Phases of Development |
Brigid Leventhal, MD |
03 Oct |
Language of the FDA -- Adequate , Director
and Well-Controlled Studies |
Curtis L. Meinert, PhD |
12 Sep |
Start-up |
Steve N. Goodman, MD, PhD |
|
| |
|
| |
|
|
